<span>Photochemical smog, created by the chemical reaction between sunlight, nitrogen oxides and volatile organic compounds is (e) generally worse during the winter months in part because of the increase in energy used to heat homes and other buildings.</span>
For the answer to the question above, I think that <span>the initial titer that has been done to her may have been done too early in the infection that detectable levels of antibody were not present yet so that's why they have to repeat it.</span>
Hello, I figured your question was missing its options so I went online to find them. Here they are:
The process of phagocytosis involves all of the following EXCEPT
:
a. adhesion.
b. secretion of cytotoxins.
c. elimination.
d. vesicle fusion.
e. chemotaxis.
Answer:
The correct answer is: b) secretion of cytotoxins.
Explanation:
Phagocytosis is a mechanism performed by cells in which the plasma membrane engulfs a large particle. Phagocytosis is used by cells in the immune system to ingest pathogens like viruses and bacteria.
Phagocytosis consists of many steps:
- activation
- the phagocytes that were resting are activated in the inflammatory response when a pathogen enters the body.
- chemotaxis - this refers to the process in which the phagocyte moves to the pathogen by following the chemical factors released by these germs.
- adhesion - the phagocyte attaches to the pathogen.
- ingestion
/vesicle fusion - the phagocyte sends pseudopods to engulf the pathogen, and places it in a phagosome, which is an endocytic vesicle. The phagosome and the phagocyte will fuse so the pathogen gets inside.
- elimination - the pathogen is destroyed in the phagocyte by the lysosomes present in it.
<u>The</u><u> secretion of cytotoxins</u><u> is not a part of the phagocytosis, and is a process exclusive to </u><u>T cells</u><u> (leukocytes that lack the ability to phagocyte).</u>
B. Catalysts are not changed during a chemical reaction.
Answer:
D. Allosteric activator
Explanation:
In an enzyme, the allosteric site is a site/motif different from the active site, (i.e., the site with catalytic activity) which is able to interact with regulatory effector molecules in order to activate or inhibit enzymatic activity by influencing the tridimensional (3D) structure of the enzyme. An allosteric activator is an effector molecule with the ability to bind to a specific enzyme at a different site than the active site, thereby modifying the shape of the enzyme and increasing the affinity of this enzyme for its substrate. Moreover, Adenosine monophosphate (AMP) is a nucleotide composed of a phosphate group, a sugar ribose, and an Adenine (A) base. This effector molecule (AMP) has shown to allosterically stimulate diverse enzymes in physiological conditions (e.g., AMP-activated protein kinase).
